Plaas A H, Sandy J D
Shriners Hospital for Crippled Children, Tampa, FL 33612.
Matrix. 1993 Mar;13(2):135-47. doi: 10.1016/s0934-8832(11)80072-7.
The structure, biosynthesis and catabolism of aggrecan has been studied in the bovine fetal rib growth plate. Comparative analyses were made on six 1-mm transverse slices which represent the resting zone (slice 6), proliferative zone (slices 5 and 4), upper hypertrophic zone (slice 3), middle hypertrophic zone (slice 2) and lower hypertrophic zone (slice 1). Aggrecan was abundant and exhibited very high aggregability in all zones. The aggrecan monomer was similar in structure in the resting and proliferative zones but showed a marked increase in hydrodynamic size in the lower hypertrophic zone; this was apparently due to an increase in the size of substituent glycosaminoglycans and an increase in core protein size as indicated by peptide analysis for G3 domain abundance. Biosynthetic studies with [35S]-sulfate showed the rate of synthesis per cell to be highest in the upper hypertrophic zone, and the structure of the newly synthesised molecules to be similar to the resident population in all zones. During explant culture in basal medium both aggregating and non-aggregating forms of aggrecan were released slowly from all zones. Addition of 10 nM retinoic acid to explants stimulated the release of both these forms of aggrecan whereas higher concentrations of retinoic acid (100 nM and 1000 nM) preferentially stimulated the release of the degraded forms. In this regard hypertrophic cells were the most responsive and resting cells were the least responsive. Analysis of the degraded fragments by polyacrylamide gel electrophoresis and by N-terminal sequencing indicated that aggrecan catabolism in all zones of the growth plate is due to the action of aggrecanase, a novel cartilage proteinase which is also active in normal and osteoarthritic articular cartilages (Sandy et al., 1992). These observations are discussed in terms of the role of aggrecan in the extensive matrix remodelling which accompanies chondrocyte hypertrophy in the growth plate.
已在牛胎儿肋骨生长板中研究了聚集蛋白聚糖的结构、生物合成和分解代谢。对六个1毫米的横向切片进行了比较分析,这些切片分别代表静止区(切片6)、增殖区(切片5和4)、上肥大区(切片3)、中肥大区(切片2)和下肥大区(切片1)。聚集蛋白聚糖在所有区域都很丰富,并且表现出非常高的聚集能力。聚集蛋白聚糖单体在静止区和增殖区的结构相似,但在下肥大区其流体力学尺寸显著增加;这显然是由于取代糖胺聚糖的尺寸增加以及核心蛋白尺寸增加,如通过对G3结构域丰度的肽分析所示。用[35S] - 硫酸盐进行的生物合成研究表明,每个细胞的合成速率在上肥大区最高,并且新合成分子的结构在所有区域都与驻留群体相似。在基础培养基中进行外植体培养期间,聚集蛋白聚糖的聚集形式和非聚集形式都从所有区域缓慢释放。向外植体中添加10 nM视黄酸会刺激这两种形式的聚集蛋白聚糖的释放,而更高浓度的视黄酸(100 nM和1000 nM)则优先刺激降解形式的释放。在这方面,肥大细胞反应最敏感,静止细胞反应最不敏感。通过聚丙烯酰胺凝胶电泳和N端测序对降解片段进行分析表明,生长板所有区域的聚集蛋白聚糖分解代谢是由于聚集蛋白聚糖酶的作用,聚集蛋白聚糖酶是一种新型软骨蛋白酶,在正常和骨关节炎关节软骨中也有活性(桑迪等人,1992年)。根据聚集蛋白聚糖在生长板中伴随软骨细胞肥大的广泛基质重塑中的作用对这些观察结果进行了讨论。